Jennifer R Glass

Summary

Affiliation: Johnson and Johnson Pharmaceutical Research and Development
Country: USA

Publications

  1. doi request reprint Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial
    Jennifer R Glass
    Faculty of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada
    J Clin Psychopharmacol 28:182-8. 2008
  2. ncbi request reprint Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects
    Jennifer R Glass
    Division of Clinical Neuroscience, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario, Canada M5S 2S1
    J Clin Psychopharmacol 23:260-8. 2003

Detail Information

Publications2

  1. doi request reprint Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial
    Jennifer R Glass
    Faculty of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada
    J Clin Psychopharmacol 28:182-8. 2008
    ..The choice of agent to use in the elderly must consider these relative benefits and risks...
  2. ncbi request reprint Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects
    Jennifer R Glass
    Division of Clinical Neuroscience, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario, Canada M5S 2S1
    J Clin Psychopharmacol 23:260-8. 2003
    ..001) but similar to that with 15 mg temazepam (NS). No psychomotor impairment was detected with 50 mg diphenhydramine. Valerian was not different from placebo on any measure of psychomotor performance or sedation...